Q3 2019 Fulcrum Therapeutics Inc Earnings Call Transcript
Good morning, and welcome to the Fulcrum Therapeutics Third Quarter 2019 Conference Call. (Operator Instructions) I would now like to turn the call over to Peter Thomas -- Peter Thomson, Vice President of Finance and Accounting at Fulcrum, please proceed.
Good morning. Welcome to Fulcrum's Third Quarter 2019 Conference Call. We issued a press release earlier today reviewing our third quarter 2019 results and business updates, which will be covered on this call. A replay of today's call will be available on the Investors and Media section of our website. After our prepared remarks, we will open the call for Q&A.
Before we begin, I'd like to mention that our call will contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These may include statements about our future expectations and plans, clinical development time lines and financial projections. I encourage you to review our filings with the Securities and Exchange
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |